Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LIPE | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | COL8A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CAND1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | MADD | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SMCHD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARGLU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | F7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CHD5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TFDP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NPM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |